Free Trial

Daré Bioscience (DARE) SEC Filings & 10K Form

Daré Bioscience logo
$2.88 -0.03 (-1.00%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Daré Bioscience SEC Filings

DateFilerForm TypeView
04/11/2025
4:15 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:01 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:01 PM
Daré Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2025
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
4:34 PM
Daré Bioscience (Issuer)
Haring-Layton MarDee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:31 PM
Daré Bioscience (Issuer)
JOHNSON SABRINA MARTUCCI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
7:05 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
11:15 PM
Daré Bioscience (Filer)
Form EFFECT
11/26/2024
4:17 PM
Daré Bioscience (Filer)
Form 424B3
11/22/2024
4:00 PM
Daré Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
11/15/2024
4:18 PM
Daré Bioscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/25/2024
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:31 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:00 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
7:05 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:15 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Matz Gregory W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Steele Robin Joan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Grossman Jessica D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:01 PM
Daré Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:05 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2024
11:15 PM
Daré Bioscience (Filer)
Form EFFECT
05/01/2024
11:16 PM
Daré Bioscience (Filer)
Form EFFECT
04/30/2024
6:45 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM
Daré Bioscience (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Daré Bioscience (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DARE) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners